Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Gut microbiome and lichen sclerosus: a two-sample bi-directional Mendelian randomization study

Jiayan Chen, Peiyan Wang, Changji Xiao, Kalibinuer Kelaimu, Xianshu Gao, Xiaomei Li, Jun Hu
doi: https://doi.org/10.1101/2024.07.23.24310907
Jiayan Chen
1Department of Radiation Oncology, Peking University First Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peiyan Wang
2School of Information, University of Michigan, Ann Arbor, MI, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changji Xiao
3Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kalibinuer Kelaimu
3Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianshu Gao
1Department of Radiation Oncology, Peking University First Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaomei Li
1Department of Radiation Oncology, Peking University First Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Hu
3Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hujunpkufh{at}bjmu.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Recent studies suggest a potential link between gut microbiomes (GMs) and inflammatory diseases, but the role of GMs in lichen sclerosus (LS) remains unclear. This study aims to investigate the causal relationship between GMs and LS, focusing on key GM taxa.

Methods We utilized GWAS summary statistics for 211 GM taxa and their association with 2,445 LS patients and 353,088 healthy controls, employing Mendelian randomization (MR). GWAS data for GM taxa came from the MiBioGen consortium, and for LS from the FinnGen consortium. The primary analytical tools included the inverse-variance weighted (IVW) method, weighted MR, simple mode, weighted median, and MR-Egger methods. Sensitivity analyses included leave-one-out analysis, MR-Egger intercept test, MR-PRESSO global test, and Cochrane’s Q-test. A reverse MR analysis was conducted on bacteria identified in the forward MR study.

Results We identified one strong causal relationship: order Burkholderiales [odds ratio (OR) = 0.420, 95% confidence interval (CI): 0.230 - 0.765, p = 0.005], and three nominally significant relationships: phylum Cyanobacteria (OR = 0.585, 95% CI: 0.373 - 0.919, p = 0.020), class Betaproteobacteria (OR = 0.403, 95% CI: 0.189 - 0.857, p = 0.018), and genus Butyrivibrio (OR = 0.678, 95% CI: 0.507 - 0.907, p = 0.009). Moreover, this MR analysis was not impacted by horizontal pleiotropy, according to the MR-Egger intercept test and MR-PRESSO global test (p > 0.05). Remarkably, the reliability of our results was confirmed by leave-one-out analysis. Reverse MR analysis showed no significant causal relationship between LS and GM.

Conclusions This MR study identifies specific gut flora linked to a lower risk of LS, offering new insights for disease treatment and prevention. Future research should incorporate metagenomics sequencing of extensive microbiome GWAS datasets.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was funded by Peking University Youth Physician Research Funding (2015QN031) and National High Level Hospital Clinical Research Funding (Scientific Research Seed Fund of Peking University First Hospital 2023SF08).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The summary data of MiBioGen can be downloaded from the website https://mibiogen.gcc.rug.nl/. The summary data of FINNGEN can be downloaded from the website https://r9.finngen.fi/. This published work and its supplementary information files contain other datasets that were generated and/or analyzed during the current study, which are accessible to the public.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • chenjiayan2019-ro{at}bjmu.edu.cn (J.-Y.C.); doctorgaoxs{at}126.com (X.-S.G.); lixiaomei1973{at}bjmu.edu.cn (X.-M.L.);

  • peiyanw{at}umich.edu (P.-Y.W.);

  • xcji1988{at}163.com (C.-J.X.); 13400052009{at}163.com (K.K.)

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

https://mibiogen.gcc.rug.nl/

https://r9.finngen.fi/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 24, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Gut microbiome and lichen sclerosus: a two-sample bi-directional Mendelian randomization study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Gut microbiome and lichen sclerosus: a two-sample bi-directional Mendelian randomization study
Jiayan Chen, Peiyan Wang, Changji Xiao, Kalibinuer Kelaimu, Xianshu Gao, Xiaomei Li, Jun Hu
medRxiv 2024.07.23.24310907; doi: https://doi.org/10.1101/2024.07.23.24310907
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Gut microbiome and lichen sclerosus: a two-sample bi-directional Mendelian randomization study
Jiayan Chen, Peiyan Wang, Changji Xiao, Kalibinuer Kelaimu, Xianshu Gao, Xiaomei Li, Jun Hu
medRxiv 2024.07.23.24310907; doi: https://doi.org/10.1101/2024.07.23.24310907

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Dermatology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)